Karavela, founded in 2025, is pioneering the development of a foundation model of the brain, leveraging next-gen magnetic resonance technology. With its slogan, "Building a foundation model of the brain with next-gen magnetic resonance," the company is poised to revolutionize the field of neurological diagnostics.
Through the use of large-scale task-based fMRI, Karavela aims to unlock new diagnostics and biomarkers for neurological diseases, which will not only enhance the understanding of these conditions but also facilitate the development of next-gen brain-computer interfaces. This ambitious undertaking could potentially shift paradigms in both the clinical and technological landscapes.
Although specific details on the company headquarters and recent investments remain undisclosed, the innovative approach and potential impact of Karavela present a compelling opportunity for investors seeking to dive into the intersection of neuroscience and advanced technology.
